National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2013 (No. 2) (No. PB 66 of 2013)

Link to law: https://www.comlaw.gov.au/Details/F2013L01738

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 66 of 2013
National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2013 (No.2)
National Health Act 1953
I, STEVE DUNLOP, Acting Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Medical Research, make this Instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated         23 September 2013
 
 
 
 
 
 
 
 
 
 
 
STEVE DUNLOP
Acting Assistant Secretary
Pharmaceutical Access Branch
Pharmaceutical Benefits Division
Department of Health
 
 
 
1       Name of Instrument
(1)          This Instrument is the National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2013 (No 2).
(2)          This Instrument may also be cited as PB 66 of 2013.
2       Commencement
This Instrument commences on 1 October 2013.
3       Amendments to National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010
Schedule 1 amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (PB 118 of 2010).
 
.
Schedule 1     Amendments
                                       
 
[1]           Schedule 1, entry for Macrogol 3350 in the form Sachets containing powder for oral solution 13.125 g with electrolytes, 30
omit from the column headed ‘Responsible Person; for the brand ‘LaxaCon’: GM substitute: GN
 
 
[2]           Schedule 2, after BY
omit:
 
GM
Ascent Pharma Pty Ltd
68 118 734 795
insert:
 
GN
Actavis Pty Ltd
17 003 854 626